Lilly to sell one of its US site to drug development services company,Covance;plans new headquarters for animal health division

摘要

Eli Lilly and Company is selling its Greenfield Laboratories site located in Greenfield,Indiana(USA)to Covance Inc,one of the world's leading drug development services companies for an upfront payment of US50-mn.The two companies will also sign a 10-year service agreement,under which Lilly and Covance will broaden their existing strategic collaboration,with Covance assuming responsibility for Lilly's toxicology testing and other R&D support activities at the site.Covance currently conducts significant preclinical toxicology and early-stage clinical work for Lilly.This collaboration,which also includes expanded early-stage clinical work and phase II/III clinical trial support,will help Lilly to lower drug development costs and speed the flow of new medicines.